Caribou Biosciences, Inc. (CRBU) Q4 2024 Annual Earnings
CRBU·Reported March 10, 2025·Before market open
Caribou Biosciences, Inc. reported Q4 2024 revenue of $2.1M, missed analyst consensus of $2.1M by $29.3K. Diluted EPS came in at $-0.39, beat the $-0.40 consensus by $0.01.
Revenue
$2.1Mmissed by $29.3K
Consensus: $2.1MDiluted EPS
$-0.39beat by $0.01
Consensus: $-0.40
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Caribou Biosciences, Inc.'s Q4 2024 earnings report.
Caribou Biosciences, Inc. (CRBU) reported Q4 2024 earnings on March 10, 2025 before market open.
Caribou Biosciences, Inc. reported revenue of $2.1M and diluted EPS of $-0.39 for Q4 2024.
Revenue missed the consensus estimate of $2.1M by $29.3K. EPS beat the consensus estimate of $-0.40 by $0.01.
You can read the 10-K periodic report (0001619856-25-000015) directly on SEC EDGAR. The filing index links above go to sec.gov.